Cefuroxime sodium salt CAS:56238-63-2
Cefuroxime sodium salt is primarily utilized in healthcare facilities for the treatment of serious bacterial infections that require intravenous therapy. This formulation of cefuroxime is especially useful in cases where oral administration may not be feasible, such as in patients with severe infections or those unable to take medications orally. Healthcare providers may prescribe cefuroxime sodium salt for various conditions, including complicated skin and soft tissue infections, intra-abdominal infections, septicemia, and pneumonia. Its broad spectrum of activity against different types of bacteria makes it a valuable option for treating a range of infections effectively. When administered intravenously, cefuroxime sodium salt is delivered directly into the bloodstream, allowing for rapid distribution throughout the body to target the site of infection. Healthcare professionals must closely monitor patients receiving cefuroxime sodium salt to ensure appropriate dosing and response to treatment. It is essential to complete the full course of treatment with cefuroxime sodium salt as prescribed by your healthcare provider to maximize its effectiveness and minimize the risk of developing antibiotic resistance. If you experience any adverse reactions or have concerns about your treatment, promptly consult your healthcare provider for further guidance and evaluation.
Composition | C16H15N4O8S.Na |
Assay | 99% |
Appearance | white powder |
CAS No. | 56238-63-2 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |